"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
Case report

Early Recovery of Sympathetic Ophthalmia with Hearing Loss in a Young Man


Hearing loss is rarely associated with sympathetic ophthalmia. We describe a young man who presented with sympathetic ophthalmia and concurrent hearing loss one month post globe rupture. The presentation was very subtle and atypical. However, the patient recovered fully after two weeks of prompt oral corticosteroid therapy which resulted in good visual and hearing outcomes. This patient demonstrated that the acute phase of sympathetic ophthalmia is reversible with early recognition of features, timely diagnosis, and rapid initiation of corticosteroid therapy.


Sympathetic ophthalmia refers to a diffuse granulomatous uveitis in both eyes. The occurrence of sympathetic ophthalmia had been reported in up to 3.1% of patients with a history of trauma to one eye [1]. It is proclaimed to develop within five days to 66 years [2]. About 70% to 80% of the cases occur within three months of ocular insult, while 90% of cases occur within one year. Sympathetic ophthalmia can have atypical associating systemic presentations such as vitiligo, poliosis, alopecia, dysacusis, and meningeal irritation [3].

Hearing loss is a rare clinical manifestation of sympathetic ophthalmia. It is more likely to occur in Vogt-Koyanagi-Harada syndrome. We describe a case of sympathetic ophthalmia with concurrent hearing loss which presented at the early stage and was treated to full recovery within two weeks.

Case Presentation

A 35-year-old Kadazan man had a firecracker injury and sustained rupture of the left globe with full thickness scleral laceration from the 12 to 6 o’clock position, uveal prolapse, and total hyphema. A skull x-ray was performed, which revealed no bony fracture or radio-opaque foreign body. He underwent a primary scleral repair in our institution. Postoperatively, the visual acuity of the left eye was no perception to light. He was prescribed guttate moxifloxacin 0.5% every two hours, guttate prednisolone every four hours, and guttate homatropine 2%  every eight hours in the injured eye. Intravenous ciprofloxacin 400 mg 12 hourly was completed for one week.

After two weeks, the injured eye became phthisical, and the cornea became opaque. The visual acuity of the right eye was 6/7.5. The anterior segment examination was normal with unremarkable fundus findings. One month later, the patient presented with a history of sudden onset of central scotoma in the right eye for three days. It was associated with difficulty in reading and tinnitus in the left ear. The patient denied symptoms of eye redness, pain, or photophobia. There was no preceding fever, neck pain, headache, or vertigo noted.

Visual acuity of the right eye was 6/7.5. The anterior segment examination showed the presence of cells 2+ with granulomatous keratic precipitates. The fundus examination revealed a focal serous retinal detachment located at the nasal and inferior areas of the macula. No vitritis was noted. The optic disc was pink and non-swollen (Figure 1A). A single Dalen Fuch nodule was observed at the superonasal area of the retina (Figure 1B).

The visual acuity of the left eye remained no perception of light. The left cornea was decompensated and hazy. Hence, it obscured a proper assessment of the anterior and posterior segments of the left eye. The intraocular pressure was 14 mmHg in the right eye and 9 mmHg in the left eye. Optical coherence tomography of right macula showed the presence of subretinal fluid in the macula (Figure 2). Fundus fluorescein angiography was not performed in this patient.

Systemic and neurological examination findings were normal. He was referred to an otolaryngology specialist for a hearing assessment. Tympanogram was bilaterally normal. Pure tone audiometry showed sensorineural deafness in the left ear (Figure 3). Hearing assessment of the right ear was normal. Blood and urine cultures did not reveal any growth, the erythrocyte sedimentation rate (ESR) was 1 mm/hour, Mantoux test was 3x3 mm induration, and the x-ray of the chest was normal. Other blood investigations for infective causes including venereal disease research laboratory (VDRL) and (human immunodeficiency virus) HIV screenings were reported negative.

He was diagnosed with sympathetic ophthalmia and was prescribed guttate dexamethasone 0.1% four hourly, guttate homatropine 2% eight hourly, and oral prednisolone 1 mg/kg daily. Five days after starting oral prednisolone, the visual acuity of the right eye improved from 6/7.5 to 6/6. Anterior chamber cells were 1+ and the fundus examination revealed minimal serous retinal detachment at the macula (Figure 4A). Repeat optical coherence tomography of the right macula demonstrated a rapid reduction of subretinal fluid collection (Figure 4B). Oral prednisolone was tapered weekly after clinical resolution of sympathetic ophthalmia was observed.

Follow-up at the second week demonstrated complete recovery from sympathetic ophthalmia in the right eye. The visual acuity stabilized at 6/6, and the anterior segment was quiet. Fundus assessment showed a normal looking macula with resolved Dalen Fuch nodule (Figure 5A). Optical coherence tomography of the right macula confirmed a complete regression of subretinal fluid collection (Figure 5B).

He was reviewed at two months and six months follow-up. Visual acuity in the right eye remained 6/6. Ocular examination showed no signs suggestive of recurrence. Hearing loss in the left ear recovered two months after treatment. Repeat pure tone audiometry revealed no recurrence (Figure 6). Oral prednisolone was stopped two months later after a gradual tapering regime.


Hearing loss is an unusual presentation in sympathetic ophthalmia. It is believed to involve a T-cell-mediated autoimmune response to melanocytes. These melanocytes are found in the uveal tract and the intermediate cell layer of stria vascularis of the cochlear duct. Sensorineural hearing loss can be a transient or permanent sequelae [4].

There were few reported cases describing sympathetic ophthalmia and concurrent hearing loss in the literature [4-7]. Table 1 summarizes these published cases of sympathetic ophthalmia and hearing loss, including our patient. Most patients presented at 4–12 weeks after an ocular insult. Four out of five patients had ocular trauma, while one occurred following a vitreo-retina surgery. Their presentation was poor visual acuity, panuveitis, dense vitritis, and bilateral hearing loss.

Authors Year Age/ Gender Risk Factors Onset SO After Insult Presenting Symptoms Eye Findings ORL Findings Treatment Duration of Recovery Final Outcome
RE LE Visual Recovery Hearing Recovery
Nirankari, et al. [5] 1970 55 / Male LE penetrating injury 2 months RE BOV & bilateral HL 20 days VA: PL, panuveitis VA: NPL, phthisis bulbi, corneoscleral tear, uveal prolapse Bilateral HL RE retrobulbar injection dexamethasone then PO dexamethasone 2 months Yes. RE 6/36 No
Comer, et al. [6] 2005 72 / Female LE trabeculectomy then LE globe rupture 25 days RE BOV & bilateral HL VA: 6/24, panuveitis (dense vitritis) VA: HM, total hyphema, uveal prolapse Bilateral HL   IVMP 1 g then PO prednisolone 20 mg daily, cyclosporine, LE pars plana lensectomy & vitrectomy 3 months   Yes. RE 6/6, LE 6/12 No
Venkatesh, et al. [7] 2013 23 / Male RE penetrating injury with IOFB 3 months BE BOV & bilateral HL VA: CF, anterior uveitis, hyperemic disc VA: PL, panuveitis (dense vitritis), exudative RD Bilateral SNHL IVMP 1.5 mg/kg 3 days then PO corticosteroid 1.5 mg/kg, azathioprine, topical prednisolone 15 months Yes. RE 6/36, LE 6/9 Yes
Kawashima, et al. [4] 2015   80 / Female RE penetrating injury 25 days Bilateral HL 5 days & BE BOV VA: NA, panuveitis VA: NA, panuveitis Bilateral moderate SNHL IVMP 1 g 3 days then PO prednisolone 1 mg/kg for 6 months 1 month Yes Yes
32 / Female RE VR surgery 2 times for myopic MH & RD 43 days BE BOV & bilateral HL VA: NA, panuveitis VA: NA, panuveitis Bilateral mild SNHL IVMP 1 g 3 days then PO prednisolone 1 mg/kg for 6 months 1 month Yes Yes
Our patient 2017 35 / Male LE globe rupture   1 month RE BOV 3 days & Left HL 1 week VA: 6/7.5, anterior uveitis, subretinal fluid VA: NPL, phthisis bulbi Left SNHL PO prednisolone 1mg/kg with tapering dose for 2 months, topical dexamethasone 2 weeks   Yes. RE 6/6 Yes

Our patient had a similar onset of presentation at four weeks after an incident of left globe rupture. He presented with features of granulomatous anterior uveitis, good visual acuity, and unilateral sensorineural hearing loss. Our patient's presentation is more subtle compared to the other patients who reported the same symptoms [4-7]. This is probably because our patient presented at the early stage of the attack. The circulating T-cells mediated autoimmune attack melanocytes in both ears without preference of laterality, which probably explains the occurrence of contralateral hearing loss in our patient. 

Systemic corticosteroid is the mainstay treatment of sympathetic ophthalmia. Immunosuppressive agents such as cyclosporine and azathioprine provide good control of inflammation while avoiding the undesirable systemic side-effects of prolonged usage of corticosteroid. Intravitreal triamcinolone acetonide is another option for treatment, but frequent injections can result in cataract formation and steroid-induced glaucoma [8]. Newer treatment modalities, such as an intravitreal fluocinolone acetonide implant, have demonstrated excellent control of non-infectious uveitis [8-9]

All of the reported patients had more severe presentations and were started with intravenous methylprednisolone. In contrast, our patient was only prescribed oral prednisolone. Three patients with hearing loss recovered well after corticosteroid therapy; two of them improved after one month and another patient recovered at 15 months [4,7]. The remaining two patients had permanent hearing loss [5-6]. This may suggest that patients who had mild to moderate hearing loss recovered well with appropriate treatment. Our patient achieved complete resolution of vision and hearing impairment at the second week of treatment, which was earlier than expected. The earliest ever reported recovery is at one month post-treatment.

Close monitoring is critical in the 4-12 weeks after ocular trauma or surgery.This is essential for early detection of subtle presentation of sympathetic ophthalmia. Thus, an appropriate treatment can be administered early with the aim of improving the prognosis and final outcome. Our patient's presentation is not a classical manifestation of sympathetic ophthalmia. However, early diagnosis and adequate corticosteroid treatment demonstrated a successful recovery of his vision and hearing. 


Diagnosis of early and atypical presentation of sympathetic ophthalmia is challenging. High index of suspicion is crucial for early identification and accurate diagnosis. Early initiation of corticosteroid therapy can result in complete resolution of the acute phase of sympathetic ophthalmia with a good final outcome.


  1. Chang GC, Young LH: Sympathetic ophthalmia. Semin Ophthalmol. 2011, 26:316-320. 10.3109/08820538.2011.588658
  2. Chan CC, Roberge RG, Whitcup SM, Nussenblatt RB: 32 cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, Md, from 1982 to 1992. Arch Ophthalmol. 1995, 113:597–600. 10.1001/archopht.1995.01100050065032
  3. Chaithanyaa N, Devireddy S, Kishore Kumar R, Gali R, Aneja V: Sympathetic ophthalmia: a review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012, 113:172–176. 10.1016/j.tripleo.2011.01.036
  4. Kawashima Y, Noguchi Y, Takase H, Takahashi M, Horie S: Bilateral hearing impairment as the initial symptom of sympathetic ophthalmia. Am J Otolaryngol. 2015, 36:606–610. 10.1016/j.amjoto.2015.02.007
  5. Nirankari MS, Khanna KK, Chawla GD, Mathur R: Sympathetic ophthalmitis with total deafness (a case report). J All Ind Ophthalmol Soc. 1970, 18:29–32.
  6. Comer M, Taylor C, Chen S, Martin K, Jordan K, Meyer P: Sympathetic ophthalmia associated with high frequency deafness. Br J Ophthalmol. 2001, 85:496. 10.1136/bjo.85.4.496
  7. Venkatesh R, Agarwal M, Ramesh VJ, Singh S, Kantha M, Biswas J: Sympathetic ophthalmia with sensorineural deafness - report of a case. J Ophthalmic Inflamm Infect. 2013, 3:65. 10.1186/1869-5760-3-65
  8. Callanan DG, Jaffe GJ, Martin DF, Pearson PA, Comstock TL: Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol. 2008, 126:1191-1201. 10.1001/archopht.126.9.1191
  9. Mahajan VB, Gehrs KM, Goldstein DA, Fischer DH, Lopez JS, Folk JC: Management of sympathetic ophthalmia with the fluocinolone acetonide implant. Ophthalmology. 2009, 116:552-557. 10.1016/j.ophtha.2008.10.024
Case report

Early Recovery of Sympathetic Ophthalmia with Hearing Loss in a Young Man

Author Information

Tan Chew-Ean

Ophthalmology, Universiti Sains Malaysia, Kota Bharu, MYS

Khairuddin Othman

Department of Ophthalmology, Queen Elizabeth Hospital, Kota Kinabalu, Sabah, Malaysia., Kota Kinabalu, MYS

Sheena Mary Alexander

Department of Ophthalmology, Queen Elizabeth Hospital, Kota Kinabalu, Sabah, Malaysia.

Ismail Shatriah Corresponding Author

Department of Ophthalmology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, MYS

Ethics Statement and Conflict of Interest Disclosures

Human subjects: Consent was obtained by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Case report

Early Recovery of Sympathetic Ophthalmia with Hearing Loss in a Young Man

Figures etc.


Scholary Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. Learn more here.